Source:http://linkedlifedata.com/resource/pubmed/id/21066979
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-11-11
|
pubmed:abstractText |
Historically, locally advanced rectal cancers with invasion of tumor into adjacent organs (T4 N1, 2 tumors) have been considered poor prognosis cancers treated with palliative intent. However with the advent of multi-modality therapy and improvement in surgical reconstructive techniques, extended resections for rectal tumors are possible with acceptable patient morbidity and excellent oncological outcomes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0354-950X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-7
|
pubmed:meshHeading |
pubmed-meshheading:21066979-Combined Modality Therapy,
pubmed-meshheading:21066979-Humans,
pubmed-meshheading:21066979-Neoplasm Recurrence, Local,
pubmed-meshheading:21066979-Pelvic Exenteration,
pubmed-meshheading:21066979-Rectal Neoplasms,
pubmed-meshheading:21066979-Survival Rate,
pubmed-meshheading:21066979-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Extended surgery and pelvic exenteration for locally advanced rectal cancer. What are the limits?
|
pubmed:affiliation |
Department of Surgery Memorial Sloan Kettering Cancer Center, New York, New York, USA.
|
pubmed:publicationType |
Journal Article
|